Space Incubatric (541890)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Reported P/E of 0.84 is extremely low on a trailing basis, if the earnings are genuine and recurring.
• Reported ROE of 106.29% is exceptional on the stated ₹0.28 book value, though it is distorted by the small equity base.
• Tiny market cap of ₹6 Cr means a small absolute addition to sales could have a large per-share impact if a real business emerges.

Concerns

• Latest quarter has sales of ₹0 Cr and net profit of ₹-0 Cr, leaving no visible operating earnings engine.
• Profit growth is -137.50% and Piotroski F-Score is 2/9, indicating severe deterioration and poor financial health.
• P/B of 6.14 means paying over six times book for a company whose ROCE is -1.57%.
• Promoter holding is not available, dividend yield is zero, and overall data is insufficient for a safe investment decision.

AI Analysis

Let me start with a hard question: what does Space Incubatric actually earn from operations? The latest quarter shows sales of ₹0 crore and a net loss of ₹0 crore. A business with no revenue and a loss cannot be valued on fundamentals. The headline P/E of 0.84 looks absurdly cheap, but that is exactly the kind of figure that traps people when the 'E' comes from one-time gains or stale data—profit growth is already -137.50%, and the Piotroski F-Score is just 2/9. I ignore that P/E. The 106.29% ROE is equally misleading. It is computed on a tiny book value of ₹0.28 per share. When the operating capital earns a ROCE of -1.57%, the franchise is not creating value; the equity base is simply too small to make the ratio meaningful. There is zero sales growth, no dividend, and promoter holding is not even disclosed. At ₹1.72 the market cap is ₹6 crore, which is 6.14 times book value. For a company reporting no sales and a negative profit, I require a huge margin of safety. There is none. The price has already moved from ₹0.16 to ₹1.72; that is speculation, not investment. In Graham's language, price is what you pay, value is what you get. Here I cannot identify dependable value. Without promoter data, debt details, or evidence of recurring earnings, this falls outside my circle of competence. I will not buy hope at a premium price. Let others chase the chart; I would rather pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer